Protein C pathway function in hematopoiesis
Protein C pathway function in hematopoiesis
批准号:
8669684
负责人:
Hartmut Karl-Heinz Weiler
金额:
$41.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-09 至 2018-03-31
关键词:
Animal ModelAnticoagulantsAnticoagulationBiologicalBlood Coagulation FactorBlood VesselsBlood coagulationBone MarrowBone Marrow PurgingBone Marrow TransplantationCause of DeathCellsCoagulation ProcessCytotoxic ChemotherapyDataDoseEndothelial CellsEndotheliumExposure toF2R geneFlow CytometryFluorouracilGeneticGoalsHematopoiesisHematopoieticHistologyInjuryKnowledgeLinkMeasuresMediatingModalityMolecularMusMyelopoiesisMyelosuppressionPancytopeniaPathway interactionsPatientsPatternPhysiologicalPopulationProtein CRadiationRadiation InjuriesRadiation therapyRadioReagentReceptor SignalingRecombinantsRecoveryResistanceRoleSignal TransductionStem cellsStressStromal CellsSupplementationSystemTestingTherapeuticTherapeutic UsesThrombomodulinTreatment EfficacyVariantWhole Organismactivated protein C receptorbasebiological adaptation to stresschemotherapycytotoxicefficacy testingmacrophagemouse modelpreventprotective effectpublic health relevanceradiation recoveryreceptorreconstitutionresponseresponse to injurystemstem cell niche
中文摘要
描述(由申请人提供):本项目研究了凝血调节剂血栓调节素和天然蛋白C途径在放射损伤和化疗的造血应激反应中的先前未知的功能。我们发现内源性Thbd-蛋白C途径是致死性辐射暴露后造血功能有效恢复所必需的,并且通过药物补充蛋白C途径功能可以预防辐射诱导的骨髓衰竭导致的死亡。本研究探讨了调节血栓调节蛋白C通路这一新发现功能的细胞和分子机制。目的1确定在正常骨髓和暴露于清髓应激(放射损伤和化疗)的骨髓中表达血栓调节蛋白的相关基质细胞和造血细胞群。目的2验证骨髓间质内皮中血栓调节蛋白的表达是骨髓抑制后造血功能正常恢复所必需的假说;并且血栓调节素的这种作用是基于其以EPCR和par1依赖的方式增强tie2-血管生成素1介导的血管干细胞生态位恢复的能力。目的3研究血栓调节蛋白在造血干细胞和祖细胞中的功能作用。这种功能可能不同于其在内皮细胞中的作用,可能涉及基质巨噬细胞在骨髓抑制的造血恢复中的支持功能的调节,以及骨髓生成的细胞自主增强。目的4描述aPC的抗凝血和细胞信号功能对其治疗的贡献
英文摘要
DESCRIPTION (provided by applicant): This project investigates a previously unknown function of the blood coagulation regulator Thrombomodulin and the natural protein C pathway in the hematopoietic stress response to radiation-injury and chemotherapy. We found that the endogenous Thbd- protein C pathway is required for the efficient recovery of hematopoiesis after lethal radiation exposure, and that pharmacologic supplementation of protein C pathway function prevents death caused by radiation-induced bone marrow failure. This proposal investigates the cellular and molecular mechanism mediating this newly discovered function of the Thrombomodulin-protein C pathway. Aim 1 identifies the as yet unknown relevant stromal and hematopoietic cell populations that express Thrombomodulin in normal bone marrow and in bone marrow exposed to myeloablative stress (radiation- injury and chemotherapy). Aim 2 tests the hypothesis that Thrombomodulin expression in stromal endothelium of the bone marrow is necessary for the normal recovery of hematopoiesis after myelosuppression; and that this effect of Thrombomodulin is based on its ability to augment in an EPCR- and PAR1-dependent manner the tie2- angiopoietin1-mediated recovery of the vascular stem cell niche. Aim 3 investigates the functional role of Thrombomodulin in hematopoietic stem and progenitor cells. This function is likely different from its role in endothelial cells and may involve the regulationof the supportive function of stromal macrophages in hematopoietic recovery from myelosuppression, as well as the cell-autonomous enhancement of myelopoiesis. Aim 4 delineates the contributions of aPC's anticoagulant and cell signaling functions to its therapeutic
efficacy in supporting hematopoietic recovery from myeloablation. These studies will document a new physiologic connection between blood coagulation and hematopoiesis, and have the potential to significantly impact the current understanding of hematopoiesis and approaches to its pharmacologic manipulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core B: Glyco-genomics and Bioinformatics
-
批准号:10321578
-
项目类别:
-
资助金额:$23.27万
-
财政年份:2021
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Core B: Glyco-genomics and Bioinformatics
-
批准号:10545007
-
项目类别:
-
资助金额:$25.86万
-
财政年份:2021
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Core B: Glyco-genomics and Bioinformatics
-
批准号:10088966
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2021
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Core C: Animal Models Core
-
批准号:10379434
-
项目类别:
-
资助金额:$14.81万
-
财政年份:2019
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Core C: Animal Models Core
-
批准号:10113375
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2019
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Core C: Animal Models Core
-
批准号:10584532
-
项目类别:
-
资助金额:$16.44万
-
财政年份:2019
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Regulation of Innate Immunity by Coagulation Receptors
-
批准号:9279265
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2016
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Regulation of Innate Immunity by Coagulation Receptors
-
批准号:9158877
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2016
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Protein C pathway function in hematopoiesis
-
批准号:9037703
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2014
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Protein C pathway function in hematopoiesis
-
批准号:9229562
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2014
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Mechanism of Activated Protein C Action in Sepsis Therapy
-
批准号:7883310
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2008
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Activated Protein C for Treatment of Radiation Combined Injury
-
批准号:7559919
-
项目类别:
-
资助金额:$27.9万
-
财政年份:2008
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Activated Protein C for Treatment of Radiation Combined Injury
-
批准号:7651281
-
项目类别:
-
资助金额:$16.71万
-
财政年份:2008
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Mechanism of Activated Protein C Action in Sepsis Therapy
-
批准号:7689753
-
项目类别:
-
资助金额:$40.29万
-
财政年份:2008
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Activated Protein C for Treatment of Radiation Combined Injury
-
批准号:8142112
-
项目类别:
-
资助金额:$41.44万
-
财政年份:2008
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Activated Protein C for Treatment of Radiation Combined Injury
-
批准号:8311572
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2008
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Mechanism of Activated Protein C Action in Sepsis Therapy
-
批准号:8105326
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2008
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Activated Protein C for Treatment of Radiation Combined Injury
-
批准号:8138839
-
项目类别:
-
资助金额:$41.82万
-
财政年份:2008
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Transgenic/Knockout Core
-
批准号:7140698
-
项目类别:
-
资助金额:$2.31万
-
财政年份:2005
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
Analysis of Ian 5 Function
-
批准号:6990076
-
项目类别:
-
资助金额:$8.87万
-
财政年份:2005
-
负责人:Hartmut Karl-Heinz Weiler
-
依托单位:
海外基金